BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10811305)

  • 1. Synthesis and characterization of a novel biodegradable antimicrobial polymer.
    Woo GL; Mittelman MW; Santerre JP
    Biomaterials; 2000 Jun; 21(12):1235-46. PubMed ID: 10811305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological characterization of a novel biodegradable antimicrobial polymer synthesized with fluoroquinolones.
    Woo GL; Yang ML; Yin HQ; Jaffer F; Mittelman MW; Santerre JP
    J Biomed Mater Res; 2002 Jan; 59(1):35-45. PubMed ID: 11745535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Synthesis and antibacterial activity of N-(aroylalkyl) ciprofloxacin].
    Hu AX; Wang YT; You TB
    Yao Xue Xue Bao; 2007 Aug; 42(8):854-7. PubMed ID: 17944234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enzyme-biomaterial interactions: effect of biosystems on degradation of polyurethanes.
    Santerre JP; Labow RS; Adams GA
    J Biomed Mater Res; 1993 Jan; 27(1):97-109. PubMed ID: 8421004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biodegradation evaluation of polyether and polyester-urethanes with oxidative and hydrolytic enzymes.
    Santerre JP; Labow RS; Duguay DG; Erfle D; Adams GA
    J Biomed Mater Res; 1994 Oct; 28(10):1187-99. PubMed ID: 7829548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucoadhesive liposomes as ocular delivery system: physical, microbiological, and in vivo assessment.
    Mehanna MM; Elmaradny HA; Samaha MW
    Drug Dev Ind Pharm; 2010 Jan; 36(1):108-18. PubMed ID: 19656004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel biocatalytic polymer-based antimicrobial coatings as potential ureteral biomaterial: preparation and in vitro performance evaluation.
    Dave RN; Joshi HM; Venugopalan VP
    Antimicrob Agents Chemother; 2011 Feb; 55(2):845-53. PubMed ID: 21135190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro elution of vancomycin from biodegradable osteoconductive calcium phosphate-polycaprolactone composite beads for treatment of osteomyelitis.
    Makarov C; Cohen V; Raz-Pasteur A; Gotman I
    Eur J Pharm Sci; 2014 Oct; 62():49-56. PubMed ID: 24859314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Release of metronidazole from electrospun poly(L-lactide-co-D/L-lactide) fibers for local periodontitis treatment.
    Reise M; Wyrwa R; Müller U; Zylinski M; Völpel A; Schnabelrauch M; Berg A; Jandt KD; Watts DC; Sigusch BW
    Dent Mater; 2012 Feb; 28(2):179-88. PubMed ID: 22226009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacterial sensitivity assessment of multifunctional polymeric coatings for airway stents.
    Goodfriend AC; Welch TR; Thomas CE; Nguyen KT; Johnson RF; Forbess JM
    J Biomed Mater Res B Appl Biomater; 2017 Oct; 105(7):2153-2161. PubMed ID: 27424845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro release of new quinolones from biodegradable systems: a comparative study.
    Andreopoulos AG; Korakis T; Dounis E; Anastasiadis A; Tzivelekis P; Kanellakopoulou K
    J Biomater Appl; 1996 Apr; 10(4):338-47. PubMed ID: 8859405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of intra-vaginal matrices from polycaprolactone for sustained release of antimicrobial agents.
    Dang NT; Turner MS; Coombes AG
    J Biomater Appl; 2013 Jul; 28(1):74-83. PubMed ID: 22684517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual effect biodegradable ciprofloxacin loaded implantable matrices for osteomyelitis: controlled release and osteointegration.
    Hanafy AF; Ali HSM; El Achy SN; Habib EE
    Drug Dev Ind Pharm; 2018 Jun; 44(6):1023-1033. PubMed ID: 29484904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial activity and biocompatibility of slow-release hyaluronic acid-antibiotic conjugated particles.
    Zhang Z; Suner SS; Blake DA; Ayyala RS; Sahiner N
    Int J Pharm; 2020 Feb; 576():119024. PubMed ID: 31926974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biodegradable Poly(ester-urethane) Carriers Exhibiting Controlled Release of Epirubicin.
    Żółtowska K; Piotrowska U; Oledzka E; Kuras M; Zgadzaj A; Sobczak M
    Pharm Res; 2017 Apr; 34(4):780-792. PubMed ID: 28120174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel gel based on an ionic complex from a dendronized polymer and ciprofloxacin: Evaluation of its use for controlled topical drug release.
    García MC; Cuggino JC; Rosset CI; Páez PL; Strumia MC; Manzo RH; Alovero FL; Alvarez Igarzabal CI; Jimenez-Kairuz AF
    Mater Sci Eng C Mater Biol Appl; 2016 Dec; 69():236-46. PubMed ID: 27612709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tailoring of alginate-gelatin microspheres properties for oral Ciprofloxacin-controlled release against Pseudomonas aeruginosa.
    Islan GA; Castro GR
    Drug Deliv; 2014 Dec; 21(8):615-26. PubMed ID: 24401147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local treatment of experimental Pseudomonas aeruginosa osteomyelitis with a biodegradable dilactide polymer releasing ciprofloxacin.
    Kanellakopoulou K; Thivaios GC; Kolia M; Dontas I; Nakopoulou L; Dounis E; Giamarellos-Bourboulis EJ; Andreopoulos A; Karagiannakos P; Giamarellou H
    Antimicrob Agents Chemother; 2008 Jul; 52(7):2335-9. PubMed ID: 18411320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibacterial quaternized gellan gum based particles for controlled release of ciprofloxacin with potential dermal applications.
    Novac O; Lisa G; Profire L; Tuchilus C; Popa MI
    Mater Sci Eng C Mater Biol Appl; 2014 Feb; 35():291-9. PubMed ID: 24411380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of ciprofloxacin-loaded Eudragit RS100 or RL100/PLGA nanoparticles.
    Dillen K; Vandervoort J; Van den Mooter G; Ludwig A
    Int J Pharm; 2006 May; 314(1):72-82. PubMed ID: 16600538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.